HCA Healthcare (NYSE:HCA) Given New $535.00 Price Target at JPMorgan Chase & Co.

robot
Abstract generation in progress

JPMorgan Chase & Co. has raised its price target for HCA Healthcare (NYSE:HCA) from $420.00 to $535.00, suggesting a potential upside of 1.52% from its current price. HCA holds a consensus “Moderate Buy” rating with an average analyst target of $530.77. The company recently exceeded quarterly EPS estimates but slightly missed revenue projections, while setting an FY2026 EPS guidance above analyst forecasts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)